Autoimmune Disease clinical trials

Explore recruiting autoimmune disease clinical trials.

Recruiting autoimmune disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autoimmune Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CAR-T cells in systemic B cell mediated autoimmune disease - CASTLE

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A phase I/II study of CAR-expressing Allogenic iPSC derived NK cells for treatment of autoiMmune disease by B cELl depletion - CARAMEL

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Anti-CD19 CAR T-Cell TherApy in Refractory Systemic Autoimmune DISeases - CATARSIS

Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2b, Randomized, Controlled Double-blind, Multicenter Study Comparing the Efficacy and Safety of Zetomipzomib (KZR-616) 30 mg or 60 mg with Placebo in Patients with Active Lupus Nephritis

Portugal, Germany, Greece, Italy, Croatia, Spain +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Safety and Preliminary Efficacy of CTX112 in Adult Participants with Relapsed/Refractory Hematologic Autoimmune Disease

Spain, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 1 Study of LBL-051 in Patients with Refractory Autoimmune Disease

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Autoimmune Disease trials by city

Autoimmune Disease in Toronto Autoimmune Disease in Vancouver Autoimmune Disease in Montreal Autoimmune Disease in Calgary Autoimmune Disease in Edmonton Autoimmune Disease in Ottawa Autoimmune Disease in Winnipeg Autoimmune Disease in Quebec City Autoimmune Disease in Hamilton Autoimmune Disease in Kitchener Autoimmune Disease in London Autoimmune Disease in Halifax Autoimmune Disease in New York Autoimmune Disease in Los Angeles Autoimmune Disease in Chicago Autoimmune Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease